Skip to main content
PatentCliff

Square Patent Portfolio

25 US patents · Average 28 claims per patent

D
Patent Strength
36/100
25
Total Patents
28
Avg Claims
2
Expiring in 2 Years
5
Expiring in 5 Years

Technology Focus Areas

TelecommunicationsH04
25 patents
Computing & Data ProcessingG06
25 patents

Patent Details

Patent #TitleGrantedExpiresClaimsStatus
10004865Method for optimized wireless communication using digitalSep 17, 2022Jan 20, 20382611.8y left
10004866Apparatus for multi-layer data encoding in neural systemsSep 17, 2004Feb 25, 202242Expired
10004867Method for optimized channel estimation in quantum communicationsJul 2, 2023May 7, 20401814.1y left
10004868System and method for low-latency data processing using AI-drivenNov 12, 2014Jan 4, 203083.7y left
10004869Method for advanced channel estimation in blockchain communicationsOct 26, 2026May 4, 20421216.1y left
10004870System for high-performance neural network processing with digitalNov 17, 2010Sep 20, 2027221.5y left
10004871System for modular neural network processing with analogMar 8, 2021Nov 17, 20371211.6y left
10004872Computer-implemented method for dynamic RF optimizationOct 14, 2008Nov 17, 202524Expired
10004873Method for configurable machine learning inference using photonicApr 23, 2003Dec 6, 20219Expired
10004874System and method for optimized data processing using blockchainFeb 4, 2020Aug 9, 20363010.3y left
10004875Method for low-latency wireless communication using RFJul 18, 2025Aug 14, 20431717.4y left
10004876Method for configurable channel estimation in CMOS communicationsDec 4, 2012Apr 5, 202993.0y left
10004877Method for configurable wireless communication using 5GMay 13, 2023May 15, 20414815.1y left
10004878Method for modular wireless communication using lidarApr 13, 2017May 24, 2033167.1y left
10004879Method for integrated channel estimation in neural communicationsNov 28, 2023Feb 18, 20403913.9y left
10004880System and method for multi-layer data processing using CMOSSep 8, 2009May 8, 2027481.1y left
10004881Method for advanced channel estimation in analog communicationsJul 11, 2007Feb 24, 202335Expired
10004882System and method for high-performance data processing using nano-scaleDec 17, 2019Feb 22, 2036429.9y left
10004883Method for advanced wireless communication using CMOSJul 15, 2020Sep 15, 20363810.4y left
10004884Method for enhanced wireless communication using MEMSNov 13, 2017Mar 7, 2034397.9y left
10004885Apparatus for multi-layer data encoding in CMOS systemsAug 17, 2011Jun 20, 2029453.2y left
10004886System for improved neural network processing with quantumMay 9, 2019Aug 12, 20362910.3y left
10004887Method for dynamic channel estimation in neural communicationsMar 13, 2021Sep 14, 20392013.4y left
10004888Method for advanced wireless communication using photonicJun 7, 2018Apr 24, 2035429.0y left
10004889Method for dynamic channel estimation in analog communicationsSep 15, 2023Jul 22, 20391913.3y left

Related Patent Portfolios

IBM

150 patents · Strength: B

Samsung

130 patents · Strength: C

Canon

90 patents · Strength: C

Microsoft

100 patents · Strength: C

Frequently Asked Questions

Square holds 25 US patents with an average of 28 claims per patent. The portfolio has a Patent Strength Score of 36/100 (Grade D).

Square has 2 patents expiring within 2 years and 5 patents expiring within 5 years. These expirations may create opportunities for competitors and generic entrants.

Square's key technology focus areas include Telecommunications, Computing & Data Processing. The portfolio spans 2 distinct technology classifications (CPC codes).

The Patent Strength Score (0-100, A-F) benchmarks a company's patent portfolio quality based on portfolio size (30%), claims breadth (25%), time remaining to expiration (25%), and portfolio diversity across technology areas (20%).

Last updated:

Patent Strength Score is based on portfolio size, claims breadth, time to expiration, and technology diversity using CPC classifications.

For this entity, the underlying data on this page comes from the FDA Orange Book and USPTO patent records. The breakdown above is the federal record; the paragraphs below add the per-entity context that makes the headline numbers usable for a real decision rather than just a data lookup.

Every number on this page links back to the FDA Orange Book and USPTO patent records; the methodology page describes the inputs, refresh cadence, and known limitations of the underlying data product.

For readers using this page as a decision input, the related-entity pages elsewhere on the site provide the comparison set. The most useful comparison for this entity is typically a peer within U.S. brand-name drugs with similar size, similar exposure, or similar geography — not the national-level summary alone.

Source: USPTO patent search, 2026.